Author

A. Ma'ayan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:metabolism & bioenergetics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Hansen· 1 shared A. Jacobs· 1 shared A. Lachmann· 1 shared B. Lee· 1 shared B. R. tenOever· 1 shared B. Shewale· 1 shared C. Stevens· 1 shared D. A. Hoagland· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. Hansen

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

PPARdelta signaling activation improves metabolic and contractile maturation of human pluripotent stem cell-derived cardiomyocytes.

N. M. Wickramasinghe, D. Sachs, B. Shewale, D. M. Gonzalez, P. Dhanan-Krishnan, D. Torre, E. LaMarca, S. Raimo, R. Dariolli, M. Serasinghe, J. Mayourian, R. Sebra, K. G. Beaumont, R. Iyengar, D. L. French, , N. C. Dubois

This study shows that activating PPARD signaling enhances metabolic and contractile maturation of human pluripotent stem cell-derived cardiomyocytes.

bioRxiv · Jul 12, 2021 · PreprintCell Biology

Modulating the transcriptional landscape of SARS-CoV-2 as an effective method for developing antiviral compounds

D. A. Hoagland, D. J. B. Clarke, R. Moeller, Y. Han, L. Yang, M. L. Wojciechowicz, A. Lachmann, K. Y. Oguntuyo, C. Stevens, B. Lee, S. Chen, A. Ma'ayan, B. R. tenOever

This study identifies antiviral compounds that reduce SARS-CoV-2 viral load by counteracting the virus-induced transcriptional landscape, without affecting viral entry or host antiviral response.

bioRxiv · Jul 12, 2020 · PreprintMicrobiology